SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Cannabis-Rx (OTCQB:CANA), a real estate company focused on opportunistically acquiring, selling/leasing real estate, and assisting in the growth of the licensed cannabis industry specific to real estate and financing, yesterday reported its first quarter 2014 results. A copy of Cannabis-Rx’s Form 10-Q filing can be viewed on The Securities and Exchange Commission’s website.
Llorn Kylo, Chief Executive Officer of Cannabis-Rx, commented, “During the first quarter we began identifying and evaluating potential investment opportunities in the regulated cannabis space. We believe we are well positioned to capitalize on the sustained strong demand for real estate and financing solutions among licensed cannabis businesses. As we expand our business to deploy capital in the cannabis industry, we will continue to make prudent investments in distressed real estate, as highlighted by our recent acquisition in Sarasota, Florida. Our near term focus is on maximizing the value of the assets in our existing portfolio and leveraging the funds generated through a sale or lease to build a portfolio of investments tied to regulated cannabis space.”
Cannabis-Rx will host a conference call on May 22, 2014 at 8:00 a.m. ET to discuss first quarter 2014 results. The conference call can be accessed by dialing 1-877-705-6003 (toll-free) or 1-201-493-6725 (toll/international) and asking for the Cannabis-Rx Quarterly Investor Update. For those unable to listen to the live broadcast, a replay will be available by dialing 1-877-870-5176 (toll-free) or 1-858-384-5517 (toll/international), pass code 13583355.
About Cannabis-Rx, Inc.
Cannabis-Rx (OTCQB: CANA) is a real estate company focused on opportunistically acquiring, selling/leasing real estate, and assisting in the growth of the cannabis industry specific to real estate and financing in states where it is licensed or permitted for medicinal and/or recreational purposes. In addition to strategically purchasing properties at a significant discount to replacement cost and rehabilitating the assets to enhance their value, the Company provides licensed cannabis-based businesses with capital and real estate opportunities to advance their growth objectives. Cannabis-Rx also plans to offer consulting services to licensed cannabis growers and operators. The Company does not, nor does it intend to, grow, distribute or sell cannabis. For additional information, please visit www.cannabis-rx.co
Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements.” These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.